Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Trial details
- Registry ID
- NCT06066580
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-Label Extension of EDG-5506 in Participants With Becker Muscular DystrophyNCT06066580 | EWTX | Phase 2 | Enrolling by invitation | 2031-02Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |